Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
9,917 results
- MelaOstrongIndependent statistical analysis of Melatonin and Osteogenic Loading on Osteopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04233112).
- Melatonin for Circadian Sleep Disorders in the Blind: Complete Statistical AnalysisIndependent statistical analysis of Melatonin for Circadian Sleep Disorders in the Blind: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00911053).
- Melatonin in Smoke-induced Vascular Injury: Complete Statistical AnalysisIndependent statistical analysis of Melatonin in Smoke-induced Vascular Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02591238).
- Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Intervention For Neurocognitive Deficits in the St. Jude Lifetime Cohort: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Melatonin Postoperative Sleep Study in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Postoperative Sleep Study in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00506064).
- Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02332928).
- Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of Melphalan and Panobinostat (LBH589) for the Treatment of Patients With Recurrent Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MELTEMIIndependent statistical analysis of A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression: Complete Statistical AnalysisIndependent statistical analysis of Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00305578).
- Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03860597).
- MEMOIndependent statistical analysis of Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: Complete Statistical AnalysisIndependent statistical analysis of Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MENDEL-2Independent statistical analysis of Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2: primary endpoint results, effect estimate with confidence interval, sample-size…
- Menopausal Sleep Fragmentation and Body Fat Gain: Complete Statistical AnalysisIndependent statistical analysis of Menopausal Sleep Fragmentation and Body Fat Gain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03047330).
- Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): Complete Statistical AnalysisIndependent statistical analysis of Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00805935).
- Mental Imagery Therapy for Autism (MITA) – an Early Intervention Computerized Language Training Program for Children With ASD: Complete Statistical AnalysisIndependent statistical analysis of Mental Imagery Therapy for Autism (MITA) - an Early Intervention Computerized Language Training Program for Children With ASD: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MERCURIndependent statistical analysis of A Study of Subcutaneous Mircera in Participants With Chronic Kidney Disease Not Treated With ESA or on Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection: Complete Statistical AnalysisIndependent statistical analysis of Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00751140).
- MERLINIndependent statistical analysis of A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MERMAID-1Independent statistical analysis of Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate…
- Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC): Complete Statistical AnalysisIndependent statistical analysis of Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Mesalamine to Reduce T Cell Activation in HIV Infection: Complete Statistical AnalysisIndependent statistical analysis of Mesalamine to Reduce T Cell Activation in HIV Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01090102).
- Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma: Complete Statistical AnalysisIndependent statistical analysis of Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MeT1Independent statistical analysis of Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects: Complete Statistical AnalysisIndependent statistical analysis of Metabolic and Clinical Effect of Alpha-lipoic Acid Administration in Schizophrenic Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Metabolic Effects of Sleep Extension in People With Obesity: Complete Statistical AnalysisIndependent statistical analysis of Metabolic Effects of Sleep Extension in People With Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03594994).
- Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients: Complete Statistical AnalysisIndependent statistical analysis of Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03743025).
- Metabolic Syndrome and Fall Risk: Complete Statistical AnalysisIndependent statistical analysis of Metabolic Syndrome and Fall Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02633891).
- MetaNeb® Chest X-ray Study: Complete Statistical AnalysisIndependent statistical analysis of MetaNeb® Chest X-ray Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02871258).
- Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): Complete Statistical AnalysisIndependent statistical analysis of Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia: Complete Statistical AnalysisIndependent statistical analysis of Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery: Complete Statistical AnalysisIndependent statistical analysis of Metformin Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01433913).
- Metformin in Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Metformin in Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02252081).
- Metformin in Non Small Cell Lung Cancer (NSCLC): Complete Statistical AnalysisIndependent statistical analysis of Metformin in Non Small Cell Lung Cancer (NSCLC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02285855).
- Metformin Pharmacology in Human Cancers: A Proof of Principle Study: Complete Statistical AnalysisIndependent statistical analysis of Metformin Pharmacology in Human Cancers: A Proof of Principle Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03477162).
- Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678080).
- Methadone vs Magnesium in Spinal Fusion: Complete Statistical AnalysisIndependent statistical analysis of Methadone vs Magnesium in Spinal Fusion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01795495).
- Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs: Complete Statistical AnalysisIndependent statistical analysis of Methenamine Hippurate Versus Trimethoprim in the Prevention of Recurrent UTIs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03077711).
- Method Comparison Study of the Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing: Complete Statistical AnalysisIndependent statistical analysis of Method Comparison Study of the Spartan FRX CYP2C19 Genotyping System Against Bi-directional Sequencing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Methods Project 4: Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of Methods Project 4: Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01867242).
- Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs: Complete Statistical AnalysisIndependent statistical analysis of Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan): Complete Statistical AnalysisIndependent statistical analysis of Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia: Complete Statistical AnalysisIndependent statistical analysis of Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage: Complete Statistical AnalysisIndependent statistical analysis of Methotrexate, Vincristine, Pegylated L-Asparaginase and Dexamethasone (MOAD) in Acute Lymphoblastic Leukemia (ALL) Salvage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI): Complete Statistical AnalysisIndependent statistical analysis of Methylphenidate (Ritalin) and Memory/Attention in Traumatic Brain Injury (TBI): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00453921).
- Methylphenidate for Apathy in Alzheimer’s Dementia: A Controlled Study: Complete Statistical AnalysisIndependent statistical analysis of Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00495820).
- METRASIndependent statistical analysis of Metabolites of Tramadol in the Postoperative Surgical Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04004481).